Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
Builds universal infrastructure for cell engineering across drug discovery and cell therapy
Pitching NFX? Send the deck from a free RoundOS data room and see which pages they read.